CRISPR-based loss-of-function genetic screens were used to target 18,053 protein-coding genes in hepatocellular carcinoma cells to identify chemotherapy-related synthetic lethal genes in these cells.
[Molecular Cancer]
7992332
{7992332:DDDDDDDD}
apa
50
1
170378
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
